Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M., Richmond, Ann, Lin, P. Charles, Moses, Harold L.·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation

Flagged first, then by citations

Show all 61 references

1 of the 61 references couldn’t be matched to a known paper.

Sorted by citations

Items 801–900 of 925

Epithelial–Mesenchymal Transition: A Link between Cancer and Inflammation
Fuxe, J., & Karlsson, M. C. I. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch3 · Cited by 2
Myeloid derived suppressor cells mediate hepatocyte proliferation and immune suppression during liver regeneration following resection
Nachmany, I., Nevo, S., Edelheit, S., Sarusi-Portuguez, A., Friedlander, G., Salame, T., Pavlov, V., Yakubovsky, O., & Pencovich, N. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00303-5 · Cited by 1
Molecular mechanisms orchestrating the origin, expansion, and function of myeloid-derived suppressor cells
Joshi, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90012-2 · Cited by 1
TGFβ betrays immunity for tumorigenesis
Minton, K. (2008) · Nature reviews. Immunology · doi:10.1038/nri2263 · Cited by 1
Myelomonocytic Subsets in Tumor Microenvironment
Ginderachter, J. A. V. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_19 · Cited by 1
The Tumor Microenvironment as Target for New Cancer Therapies
Schwendener, R. A., & Mete, S. (2014) · Cited by 1
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_3 · Cited by 1
Cancer Immunotherapy: Overview in Brief
Beckhove, P. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_23 · Cited by 1
Regulation of Tumor Progression and Metastasis by Bone Marrow-Derived Microenvironments
Rayes, T. E., Gao, D., Altorki, N. K., Cox, T. R., Erler, J. T., & Mittal, V. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_13 · Cited by 1
Myeloid-derived Suppressor Cells in Cancer: A Review on the Pathogenesis and Therapeutic Potentials
Richard, S. A. (2018) · The Open Cancer Immunology Journal · doi:10.2174/1876401001807010016 · Cited by 1
The Multifunctional Roles of TGF-β in Navigating the Metastatic Cascade
Wendt, M. K., & Schiemann, W. P. (2013) · Springer eBooks · doi:10.1007/978-4-431-54409-8_7 · Cited by 1
The Role of Myeloid Derived Suppressor Cells in Cancer
Weiss, J. M. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_16 · Cited by 1
Mechanisms of Carcinogenesis in Colorectal Cancer
Shu, S., & Cheng, J. Q. (2010) · Springer eBooks · doi:10.1007/978-90-481-3725-1_18 · Cited by 1
The Immune System of Cancer Patients
Torronteguy, C., & Bonorino, A. P. S. E. C. (2011) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152311797928126 · Cited by 1
Targeted delivery and reprogramming of myeloid-derived suppressor cells (MDSCs) in cancer
Katoh, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00015-4 · Cited by 1
Cancer Immunotherapy
DOW, S. W., & Guth, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-59496-7.00014-1 · Cited by 1
Role of Tumour-Associated Macrophages in Colon Cancer Progression and Its Therapeutic Targeting
Mehta, A., Soni, V. K., Ratre, Y. K., Amit, A., Shukla, D., Kumar, A., & Vishvakarma, N. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-72702-4_10 · Cited by 1
Human MDSCs
Kochan, G. T. (2016) · SpringerBriefs in immunology · doi:10.1007/978-3-319-26821-7_3 · Cited by 1
Immune Surveillance and Tumor Evasion
Jung, M. K. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0040-0_10 · Cited by 1
The Interface of Metastatic Tumours and the Immune System
Muhsin, M.-R. K. (2012) · Otago University Research Archive (University of Otago) · Cited by 1
Gedruckt mit Erlaubnis der Medizinischen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg
Schüttler, J. (2009) · Cited by 1
Premetastatic Niches
Bennewith, K. L., Erler, J. T., & Giaccia, A. J. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch8 · Cited by 1
Cell-Cell Interaction | Chemokine Receptors
Raman, D., Howard, C. M., Tilley, A. M. C., & Sridharan, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00083-9 · Cited by 1
Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1Preprint
Boccia, T., Pan, W., Fattori, V., Cervantes‐Díaz, R., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611736 · Cited by 1
Mechanisms of Resistance to VEGF-Directed Therapy and Implications for Future Trial Design
Mier, J. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_14
Functional networks of events that modulate phenotypic manifestation of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.012
MOLECULAR MECHANISMS OF THROMBOXANE A2 RECEPTOR-MEDIATED INVASION IN LUNG CANCER CELLS
Li, X. (2012) · UKnowledge (University of Kentucky)
Chemotherapeutic Targeting of Fibulin-5 to Suppress Breast Cancer Invasion and Metastasis Stimulated by Transforming Growth Factor-Beta
Schiemann, W. P. (2012) · doi:10.21236/ada586555
Small talk in the tumor microenvironment - the contribution of fibroblasts and endothelial cells to the malignant phenotype
Anderberg, C. (2011) · Figshare
Tumor Immunotherapy by Utilizing a Double-Edged Sword, Chemokines
Mukaida, N., Sasaki, S., & Baba, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_4
Immuntherapie von Tumoren mit den Pattern-Recognition-Rezeptor-Liganden CpG und poly(I:C) hemmt die Funktion myeloischer Suppressorzellen
Bittner, P. M. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.15229
The Clinical Impact of the Dendritic Cell-based Cancer Vaccine: the Role in the Inflammatory Tumor Micro-environment
Lee, H. (2010) · Chonnam Medical Journal · doi:10.4068/cmj.2010.46.1.1
Myeloid derived suppressor cells in patients with Pancreatic Adenocarcinoma
Khaled, Y. S. (2014) · [Thesis]. Manchester, UK: The University of Manchester; 2014.
The Pro-inflammatory Milieu and Its Role in Malignant Epithelial Initiation
Yagui‐Beltrán, A., Tang, Q., & Jablons, D. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_20
Regulation of TGF-β Signaling and Metastatic Progression by Tumor Microenvironments
Wendt, M. K., & Schiemann, W. P. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_5
T cytotoxic 17 cells suppress the inflammatory reaction by regulating chemokines in colonic cancer
Liu, H., Song, J., Yang, Z., & Zhang, X. (2013) · Central European Journal of Immunology · doi:10.5114/ceji.2013.39759
Review on role of Myeloid-derived Suppressor cells in regulation of immune system
Mesali, H., Shadman, M., Tehrani, M., & Ajami, A. (2013) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences
A New Approach to Cancer Therapy: The Tumor Microenvironment as Target
Schwendener, R. A., & Mete, S. (2014) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-102646
Development of Resistance to Targeted Therapy: Preclinical Findings and Clinical Relevance
Mier, J. W., Bhatt, R. S., Panka, D. J., & Atkins, M. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_16
Angiopoietins and Other Non-VEGF Antiangiogenic Targets in Advanced Renal Cell Carcinoma
Cowey, C. L., & Hutson, T. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_7
Role of Smad4 loss in head and neck squamous cell carcinoma
Bornstein, S. (2008) · doi:10.6083/m4862ddg
A study on crosstalk between lung carcinoma and immune cells
Mushtaq, Q. D. (2012) · Shodhganga
The role of myeloid cells in breast cancer metastasis
Swierczak, A. (2012) · Minerva Access (University of Melbourne)
Role of Bone Marrow-Derived CCR1+ Cells in Colon Cancer Invasion and Metastasis
Taketo, M. M. (2015) · Springer eBooks · doi:10.1007/978-4-431-55327-4_1
Dissecting the molecular mechanisms of breast cancer bone metastasis for therapeutic targeting
Pollari, S. (2012) · UTUPub (University of Turku)
Post-Surgical Natural Killer T Cell Activation as a Potential Therapy for Metastatic Breast Cancer
Clattenburg, D. R. (2015)
A Mechanism and Pro-migratory Function for Non-canonical TGFβ Signaling Through
Liu, I. M. (2008)
Lipid-based cancer vaccines
Vasievich, E. A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jsg4-4558
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis Leah M. CookXuemei CaoAlexander E. DowellMichael T. Debies • Mick D. EdmondsBenjamin H. BeckRobert A. KestersonRenee A. Desmond • Andra R. FrostDouglas R. HurstDanny R. Welch
Hurst, R., Welch, D. R., Desmond, A. J., Kesterson, R. A., Frost, R., & Welch, R. (2012)
Immunosuppressive myeloid cells under normal and neoplastic conditions
Hamilton, M. J. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0072452
Immunomodulation of myeloid-derived suppressor cells by particulate b-glucan in cancer.
Albeituni, S. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2332
Signal Transducer and Activation of Transcription 3: A Master Regulator of Myeloid-Derived Suppressor Cells
Breckpot, K. (2016) · SpringerBriefs in immunology · doi:10.1007/978-3-319-26821-7_6
[Myeloid-derived suppressor cell expression and significance in peripheral blood and tongue lesions of mouse].
Mei, C., Guiqing, L., Wen, T., Yuan, Z., Yuxiong, S., & Yujie, L. (2015) · PubMed Central · doi:10.7518/hxkq.2015.06.005
Controversies in Neoplastic Myeloplasia
Talmadge, J. E. (2016) · SpringerBriefs in immunology · doi:10.1007/978-3-319-26821-7_1
Transforming growth factor-beta1 activation and transforming growth factor-beta receptor 2 expression levels in the regulation of the TGF-beta signaling pathway
Rojas, A. (2008) · Europe PMC (PubMed Central)
Effects of alterations to the tumor microenvironment driven by transforming growth factor beta on tumor progression
Pickup, M. W. (2013)
The novel roles of stromal fibroblasts in metronomic chemotherapy: Focusing on cancer stemness and immunity
Liao, W., Chan, T., & Tsai, K. K. (2017) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2017.08.001
Paraneoplastic Leukemoid Reaction in Solid Tumors, A Benign Syndrome of Poor Prognosis: Short Review of Literature
Hachem, G. E. (2017) · International Journal of Cancer and Oncology · doi:10.15436/2377-0902.17.1703
Multi-target analysis of neoplasms for the evaluation of tumor progression: stochastic approach of biologic processes
Al‐Hashimi, F., & Díaz‐Cano, S. J. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.14
THE IMPACT OF HISTAMINE RECEPTOR 2 ANTAGONISTS ON BREAST CANCER DEVELOPMENT AND MONOCYTIC POPULATIONS
Vila, A. (2018) · DalSpace (Dalhousie University)
Metastatic Tumors and Bone
Sterling, J. A. R., & Johnson, R. W. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch97
Basic science: (January 2008)
Sutherland, R. L. (2008) · Breast Cancer Online · doi:10.1017/s1470903108008298
TREATMENT OF LIVER METASTASIS VIA NANOPARTICLE DELIVERY OF ENGINEERED GENE IMMUNOTHERAPIES EXPRESSED LOCALLY AND TRANSIENTLY BY THE LIVER HEPATOCYTES
Goodwin, T. J. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/1c1c-8819
Systemic Correlates of the Tumor Microenvironment
Wang, L., & Lee, P. P. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_3
MECHANISM OF MYELOID-DERIVED SUPPRESSOR CELL ACCUMULATION IN CANCER AND SUSCEPTIBILITY TO REVERSAL BY SUNITINIB
Ko, J. S. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Targeting CD155 on Myeloid Derived Suppressor Cells to Prevent Postoperative Immunosuppression in Cancer Patients
Martel, A. B. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-25375
Role of TGF-β signaling in carcinoma cell migration and tumor progression
Matise, L. A. (2012)
Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells
Panka, D. J., Liu, Q., Geissler, A. K., & Mier, J. W. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01379-7
Retracted
TGFβ Signaling in Head and Neck Cancer Development and Metastases
Malkoski, S. P., Lighthall, J. G., & Wang, X.-J. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0775-2_8
The role of LL-37 in prostate cancer and its potential as a therapeutic target
Hensel, J. A. (n.d.) · ProQuest Demo Repository
Cancer Microenvironments as Therapeutic Targets
Kumar, S., & Coussens, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01909-2
Role of Arginase 1 and Nitric Oxide Synthase 2 as enzymatic mediators of the immunosuppressive activity in tumor-infiltrating myeloid derived suppressor cells
Zilio, S. (2012) · Padua Research Archive (University of Padova)
A Risk Model Composed of Six Immune Genes to Predict the Prognosis and Immunotherapy Response for Gastric CancerPreprint
Dong, H., Zhao, S., Zhang, C., & Wang, X. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3996889
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_2
Chemokine CCL15
Richter, R., Gupta, S., & Forssmann, U. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_238
Localized osteolysis
(Sterling), J. A. R., Johnson, R. W., & Lynch, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00055-5
Molecular Psychology
郝, 静. (2019) · Interdisciplinary Science Letters · doi:10.12677/isl.2019.31001
Regulation of Tumor Progression and Metastasis by Bone Marrow-Derived Microenvironments
Ramchandani, D., Rayes, T. P. E., Gao, D., Altorki, N. K., Cox, T. R., Erler, J. T., & Mittal, V. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_14
Chemokine CCL15
Richter, R., Gupta, S., & Forssmann, U. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_238-1
Cancer Traits; Present and Future
Asseri, K. A., & Aldahish, A. A. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010005
CXCL2 promoted lymphatic metastasis in endometrial cancer by regulating STMN1 related ferroptosisPreprint
Mao, Y., Liu, G., Fu, H., Li, J., Tang, Q.-L., & Jiang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2848748/v1
Deletion of CUL4B in gut epithelium promotes ApcMin/+ adenoma formation by impacting the microenvironmentPreprint
Guo, B., Zheng, Y., Fan, Y., Yang, Y., Wang, Y., Qin, L., An, Y., Xu, X., Zhang, X., Sun, G., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3050354/v1
Local Onco-Sphere: Tumor–Secretome Interaction
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_5
Distal Onco-Sphere: Molecular Mechanisms in Metastasis
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_14
The Characteristics Of Tumor Microenvironment In Colorectal Cancer With Different Msi Status And Current Therapeutic StrategiesPreprint
Wang, Q., Yu, M., & Zhang, S. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4617358
Additional file 15 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802314
Additional file 14 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802311
Additional file 13 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802305
Additional file 12 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802302
Additional file 10 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802296
Additional file 11 of Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19802299
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Ramin, S., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00085-1
WITHDRAWN: Molecular mechanisms orchestrating the origin, expansion, and function of myeloid-derived suppressor cells
Joshi, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00012-6
Tumor microenvironment and metastatic progression of cancer
Hong, E., Park, S., Kim, S., & Ooshima, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824040-3.00006-6
Preliminary Exploration of the Relationship between Tumor Microenvironment in Malignant Ascites and Patient PrognosisPreprint
Wang, Q., Cheng, C., Wang, R., Zhang, S., & Jiang, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4680957/v1
Adjuvant Conditioning Shapes the Adaptive Immunity and Promotes Trained Immunotolerance via NLRP3/IL-1Preprint
Boccia, T., Pan, W., Fattori, V., Cervantes‐Díaz, R., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4977885
Research Advances on IL-1β and IL-6 in Chronic Atrophic Gastritis and Primary Sjögren’s Syndrome
高, 润. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551387
Enhancing CAR-T Efficacy: The Role of Anti PD-1/PD-L1 Checkpoint Inhibitors in Modern Cancer Treatment
Kant, R., Roy, P., Kaur, A., & Kumar, R. (2025) · Journal of Coloproctology · doi:10.1055/s-0045-1809675
Avaliação das atividades citotóxicas e imunomoduladora de paládio(II) contendo o ligante DMBA= N,N-dimetilbenzilamina.
Jardim, M. G. D. (2014) · Americanae (AECID Library)
Rol del factor de crecimiento transformante beta en la progresión del cáncer de pulmón
Carlini, M. J. (2013) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks